Similar companies
Did Apimeds Pharmaceuticals Beat Earnings?
Apimeds Pharmaceuticals (APUS) reported Q2 '26 revenue of $0.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Apimeds Pharmaceuticals’s job postings, web traffic, and employee business outlook. See the full APUS stock analysis or the earnings calendar for upcoming reports.
Apimeds Pharmaceuticals Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net income | -330,000 | -310,000 | -400,000 | -2.7M | -1.8M | -1.2M | -35M | -20M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
Apimeds Pharmaceuticals Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Apimeds Pharmaceuticals’s quarterly revenue moved from $0 to $0.
When Is Apimeds Pharmaceuticals’s Next Earnings Date?
Apimeds Pharmaceuticals reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the APUS earnings calendar.
Frequently Asked Questions: Apimeds Pharmaceuticals Earnings
Apimeds Pharmaceuticals's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Apimeds Pharmaceuticals reported Q2 '26 revenue of $0.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the APUS AI Score.
